Nanogen/Prodesse aim for rapid infection detection
This article was originally published in Clinica
Executive Summary
Nanogen has teamed up with a small, privately held biotech company based in Milwaukee, Wisconsin, to develop rapid gene-based tests for infectious disease agents.